ADS051, AN ORAL, GUT-RESTRICTED, SMALL MOLECULE NEUTROPHIL MODULATOR IN PATIENTS WITH MODERATE-TO-SEVERE ULCERATIVE COLITIS RECEIVING MULTIPLE ASCENDING DOSES

Jessica Allegretti  1     Adam S. Cheifetz  2, 3     Parambir S. Dulai  4     A. C. Stevens  5     Jillian Chapas-Reed  6     Laurent Chesnel  6     Bharat Dixit  6     Ronald Farquhar  6     Parviz Ghahramani  7     Benjamin Miller  7     Christopher Murphy  7     Megan Quintas  7     Raisa Tanase  8     Tengiz Telia  9     Barbara Wozniak-Stolarska  10     Renu Gupta  10    
1 Brigham and Women's Hospital Division of Gastroenterology, Cambridge, United States
2 Beth Israel Deaconess Medical Center, Boston, United States
3 Harvard Medical School, Boston, United States
4 Northwestern University Feinberg School of Medicine, Chicago, United States
5 Independent Biopharmaceutical Consultant, Boston, United States
6 Adiso Therapeutics, Inc., Concord, United States
7 Inncelerex, Jersey City, United States
8 ARENSIA Exploratory Medicine, Republican Clinical Hospital, Chisinau, Moldova, Republic of
9 ARENSIA Exploratory Medicine LLC, Tbilisi, Georgia
10 PlanetMed Gastroenterology Sp. z o.o., Wroclaw, Poland

Topic
Colorectal

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing